NO20013910L - Fosforamidat, og mono-, di- og tri-fosfatestere av (1R, cis)- 4-(6-amino-9H-purin-9-yl)-2-syklopenten-1-metanol som antiviralemidler - Google Patents

Fosforamidat, og mono-, di- og tri-fosfatestere av (1R, cis)- 4-(6-amino-9H-purin-9-yl)-2-syklopenten-1-metanol som antiviralemidler

Info

Publication number
NO20013910L
NO20013910L NO20013910A NO20013910A NO20013910L NO 20013910 L NO20013910 L NO 20013910L NO 20013910 A NO20013910 A NO 20013910A NO 20013910 A NO20013910 A NO 20013910A NO 20013910 L NO20013910 L NO 20013910L
Authority
NO
Norway
Prior art keywords
cyclopenten
purin
antivirals
phosphoramidate
cis
Prior art date
Application number
NO20013910A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013910D0 (no
Inventor
Susan Mary Daluge
Christopher Mcguigan
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9903090.0A external-priority patent/GB9903090D0/en
Application filed by Univ Cardiff filed Critical Univ Cardiff
Publication of NO20013910D0 publication Critical patent/NO20013910D0/no
Publication of NO20013910L publication Critical patent/NO20013910L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20013910A 1999-02-12 2001-08-10 Fosforamidat, og mono-, di- og tri-fosfatestere av (1R, cis)- 4-(6-amino-9H-purin-9-yl)-2-syklopenten-1-metanol som antiviralemidler NO20013910L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9903090.0A GB9903090D0 (en) 1999-02-12 1999-02-12 Therapeutic compounds
US17020599P 1999-12-10 1999-12-10
PCT/EP2000/001045 WO2000047591A1 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents

Publications (2)

Publication Number Publication Date
NO20013910D0 NO20013910D0 (no) 2001-08-10
NO20013910L true NO20013910L (no) 2001-10-10

Family

ID=26315118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013910A NO20013910L (no) 1999-02-12 2001-08-10 Fosforamidat, og mono-, di- og tri-fosfatestere av (1R, cis)- 4-(6-amino-9H-purin-9-yl)-2-syklopenten-1-metanol som antiviralemidler

Country Status (24)

Country Link
US (1) US7115590B1 (xx)
EP (1) EP1150988B1 (xx)
JP (1) JP2002536452A (xx)
KR (1) KR20010102082A (xx)
CN (1) CN1346360A (xx)
AR (1) AR031975A1 (xx)
AT (1) ATE241633T1 (xx)
AU (1) AU772478B2 (xx)
BR (1) BR0008135A (xx)
CA (1) CA2362662A1 (xx)
CZ (1) CZ20012908A3 (xx)
DE (1) DE60002986T2 (xx)
DK (1) DK1150988T3 (xx)
DZ (1) DZ3007A1 (xx)
ES (1) ES2200820T3 (xx)
HK (1) HK1039337B (xx)
HU (1) HUP0105476A3 (xx)
IL (1) IL144647A0 (xx)
NO (1) NO20013910L (xx)
NZ (1) NZ513450A (xx)
PL (1) PL204458B1 (xx)
PT (1) PT1150988E (xx)
TR (1) TR200102313T2 (xx)
WO (1) WO2000047591A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2576001A (en) * 1999-12-10 2001-06-18 Glaxo Group Limited (1r,cis)-4-(4-amino-7h-pyrrolo'2,3-i(d) pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral
PE20010915A1 (es) * 1999-12-10 2001-09-29 Glaxo Group Ltd Analogos de (1s, cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales
JP5230052B2 (ja) 2000-05-26 2013-07-10 イデニクス（ケイマン）リミテツド フラビウイルスおよびペスチウイルス治療のための方法および組成物
AU2001282941C1 (en) † 2000-07-21 2016-12-22 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
GB0129945D0 (en) * 2001-12-13 2002-02-06 Mrc Technology Ltd Chemical compounds
GB0401088D0 (en) 2004-01-19 2004-02-18 Univ Cardiff Phosphoramidate derivatives
EP2691409B1 (en) 2011-03-31 2018-02-21 Idenix Pharmaceuticals LLC. Compounds and pharmaceutical compositions for the treatment of viral infections
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
EP2768838A1 (en) 2011-10-14 2014-08-27 IDENIX Pharmaceuticals, Inc. Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
US9109001B2 (en) 2012-05-22 2015-08-18 Idenix Pharmaceuticals, Inc. 3′,5′-cyclic phosphoramidate prodrugs for HCV infection
AU2013266393B2 (en) 2012-05-22 2017-09-28 Idenix Pharmaceuticals Llc D-amino acid compounds for liver disease
WO2013177195A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphate prodrugs for hcv infection
EA027929B1 (ru) 2012-05-25 2017-09-29 Янссен Сайенсиз Айрлэнд Юси Нуклеозиды на основе урацила и спирооксетана
EP2900682A1 (en) 2012-09-27 2015-08-05 IDENIX Pharmaceuticals, Inc. Esters and malonates of sate prodrugs
US10513534B2 (en) 2012-10-08 2019-12-24 Idenix Pharmaceuticals Llc 2′-chloro nucleoside analogs for HCV infection
US10723754B2 (en) 2012-10-22 2020-07-28 Idenix Pharmaceuticals Llc 2′,4′-bridged nucleosides for HCV infection
EP2935304A1 (en) 2012-12-19 2015-10-28 IDENIX Pharmaceuticals, Inc. 4'-fluoro nucleosides for the treatment of hcv
EP2970358B1 (en) 2013-03-04 2021-06-30 Idenix Pharmaceuticals LLC 3'-deoxy nucleosides for the treatment of hcv
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
EP2970357A1 (en) 2013-03-13 2016-01-20 IDENIX Pharmaceuticals, Inc. Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
WO2014165542A1 (en) 2013-04-01 2014-10-09 Idenix Pharmaceuticals, Inc. 2',4'-fluoro nucleosides for the treatment of hcv
WO2014197578A1 (en) 2013-06-05 2014-12-11 Idenix Pharmaceuticals, Inc. 1',4'-thio nucleosides for the treatment of hcv
WO2015017713A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
EP3131914B1 (en) 2014-04-16 2023-05-10 Idenix Pharmaceuticals LLC 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
GEP20247600B (en) 2015-03-06 2024-02-26 Atea Pharmaceuticals Inc B-D-2'-DEOXY-2'a-FLUORO-2'-B-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
US10711029B2 (en) 2016-07-14 2020-07-14 Atea Pharmaceuticals, Inc. Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
EP3512863B1 (en) 2016-09-07 2021-12-08 ATEA Pharmaceuticals, Inc. 2'-substituted-n6-substituted purine nucleotides for rna virus treatment
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
WO2021173713A1 (en) 2020-02-27 2021-09-02 Atea Pharmaceuticals, Inc. Highly active compounds against covid-19
WO2024107859A1 (en) * 2022-11-15 2024-05-23 Rome Therapeutics, Inc. Cyclopentene-oxymethylene phosphonamidates and related compounds and their use in treating medical conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244896A (en) * 1990-09-14 1993-09-14 Marion Merrell Dow Inc. Carbocyclic adenosine analogs useful as immunosuppressants
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
US6887707B2 (en) * 1996-10-28 2005-05-03 University Of Washington Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
AU2576001A (en) * 1999-12-10 2001-06-18 Glaxo Group Limited (1r,cis)-4-(4-amino-7h-pyrrolo'2,3-i(d) pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral
US20030096833A1 (en) * 2001-08-31 2003-05-22 Jagtap Prakash G. Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof

Also Published As

Publication number Publication date
PT1150988E (pt) 2003-10-31
AR031975A1 (es) 2003-10-22
IL144647A0 (en) 2002-05-23
HUP0105476A2 (en) 2002-06-29
ES2200820T3 (es) 2004-03-16
KR20010102082A (ko) 2001-11-15
DK1150988T3 (da) 2003-09-29
NO20013910D0 (no) 2001-08-10
AU772478B2 (en) 2004-04-29
DE60002986D1 (en) 2003-07-03
DZ3007A1 (fr) 2003-03-27
NZ513450A (en) 2004-03-26
TR200102313T2 (tr) 2002-03-21
EP1150988B1 (en) 2003-05-28
CZ20012908A3 (cs) 2002-10-16
CA2362662A1 (en) 2000-08-17
US7115590B1 (en) 2006-10-03
DE60002986T2 (de) 2004-05-19
EP1150988A1 (en) 2001-11-07
PL350023A1 (en) 2002-10-21
HK1039337B (zh) 2003-11-21
AU2671300A (en) 2000-08-29
CN1346360A (zh) 2002-04-24
WO2000047591A1 (en) 2000-08-17
HUP0105476A3 (en) 2002-08-28
ATE241633T1 (de) 2003-06-15
HK1039337A1 (en) 2002-04-19
JP2002536452A (ja) 2002-10-29
BR0008135A (pt) 2002-02-19
PL204458B1 (pl) 2010-01-29

Similar Documents

Publication Publication Date Title
NO20013910L (no) Fosforamidat, og mono-, di- og tri-fosfatestere av (1R, cis)- 4-(6-amino-9H-purin-9-yl)-2-syklopenten-1-metanol som antiviralemidler
EP1417556A4 (en) SYNCHRONIZATION BETWEEN SEVERAL BROWSERS
AU2001236746A1 (en) Convection steamer
NO972592D0 (no) Parasittformuleringer som kan påföres dermalt
DK1202733T3 (da) 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler
NO20012058D0 (no) 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
AU3673001A (en) Minimal maintenance link to support synchronization
FR13C0072I1 (fr) Nouvelle composition de vaccin
HUP0302230A3 (en) Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
NO20040125L (no) Enterale formuleringer
NO20013242D0 (no) Benzopyraner og benzoksepiner, farmasöytiske preparater som omfatter dem, og fremgangsmåte for fremstilling av dem
DK0950657T3 (da) Substituerede carbazoler, fremgangsmåde til deres fremstilling og deres anvendelse som sPLA2-inhibitorer
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
NO20023643L (no) Forbindelser som har antitumoraktivitet, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholderdem
ZA9811833B (en) Pharmaceutical compositions of uridine triphosphate.
PT1446107E (pt) Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
GB2365360B (en) Racing simulation system
DE60125360D1 (de) Abfrageprüfgerät, das Überabtastung zur Synchronisierung verwendet
DK1341753T3 (da) Cyclohexyl (alkyl) -propanolaminer, deres fremstilling, og farmaceutiske sammensætninger, der indeholder dem
IT1311568B1 (it) Arnese da cucina per agitare, sbattere e smuovere.
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
GB2372702B (en) Fosinopril sodium tablet formulation
FI20012292A (fi) Kasvisvalmiste
ES1052634Y (es) Peladora de almendra, semilla de albaricoque y productos similares.
ZA200106551B (en) Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application